Page last updated: 2024-11-05

carbon tetrabromide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

tetrabromomethane : A one-carbon compound substituted by 4 bromo groups. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID11205
CHEBI ID47875
MeSH IDM0098648

Synonyms (59)

Synonym
nlh657095l ,
bromid uhlicity
carbon tetrabromide [un2516] [poison]
4-01-00-00085 (beilstein handbook reference)
unii-nlh657095l
nsc6179
nsc-6179
methane, tetrabromo-
558-13-4
methane tetrabromide
carbon bromide (cbr4)
carbon tetrabromide
tetrabromomethane
wln: exeee
carbon bromide
einecs 209-189-6
bromid uhlicity [czech]
nsc 6179
hsdb 2032
un2516
brn 1732799
methane, tetrabromide
tetrabromomethane, reagentplus(r), 99%
tetrabromidocarbon
kohlenstofftetrabromid
CHEBI:47875 ,
tetrabromkohlenstoff
tetrabrommethan
cbr4
T0038
tetrakis(bromanyl)methane
A830822
AKOS009107208
carbon tetrabromide, 98% (dry wt.), may cont. up to ca 6% water
FT-0623479
tetrabromomethane [hsdb]
tetrabromo methane
tetrabromocarbon
carbon tetra-bromide
tetra-bromomethane
carbon tetra bromide
tetrabromo-methane
carbontetrabromide
tetrabromometliane
perbromomethane
DTXSID8060327 ,
un 2516
tetra bromo methane
F1905-7234
tetrabromomethane, purum, >=97.0% (gc)
carbon tetrabromide, vacuum sublimed
mfcd00000117
Q423556
BP-14002
E78846
carbon-bromide
methylenebis(phosphonicdichloride)
dtxcid7041968
carboneum bromatum
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
bromomethanesA halomethane that is methane in which one or more hydrogens has been replaced by bromine.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (22)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (13.64)18.7374
1990's0 (0.00)18.2507
2000's9 (40.91)29.6817
2010's8 (36.36)24.3611
2020's2 (9.09)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 66.87

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index66.87 (24.57)
Research Supply Index3.14 (2.92)
Research Growth Index4.92 (4.65)
Search Engine Demand Index108.37 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (66.87)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other22 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]